Dynamical intervention planning against COVID-19-like epidemics
- PMID: 35700170
- PMCID: PMC9197046
- DOI: 10.1371/journal.pone.0269830
Dynamical intervention planning against COVID-19-like epidemics
Abstract
COVID-19 has got us to face a new situation where, for the lack of ready-to-use vaccines, it is necessary to support vaccination with complex non-pharmaceutical strategies. In this paper, we provide a novel Mixed Integer Nonlinear Programming formulation for fine-grained optimal intervention planning (i.e., at the level of the single day) against newborn epidemics like COVID-19, where a modified SIR model accounting for heterogeneous population classes, social distancing and several types of vaccines (each with its efficacy and delayed effects), allows us to plan an optimal mixed strategy (both pharmaceutical and non-pharmaceutical) that takes into account both the vaccine availability in limited batches at selected time instants and the need for second doses while keeping hospitalizations and intensive care occupancy below a threshold and requiring that new infections die out at the end of the planning horizon. In order to show the effectiveness of the proposed formulation, we analyze a case study for Italy with realistic parameters.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures









Similar articles
-
Controlling epidemic diseases based only on social distancing level: General case.ISA Trans. 2022 May;124:21-30. doi: 10.1016/j.isatra.2021.05.004. Epub 2021 May 8. ISA Trans. 2022. PMID: 34016439 Free PMC article.
-
Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.Front Public Health. 2023 Apr 24;11:1129183. doi: 10.3389/fpubh.2023.1129183. eCollection 2023. Front Public Health. 2023. PMID: 37168073 Free PMC article.
-
Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use.Vaccine. 2021 Apr 15;39(16):2295-2302. doi: 10.1016/j.vaccine.2021.02.056. Epub 2021 Feb 27. Vaccine. 2021. PMID: 33771391 Free PMC article.
-
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5. Encephale. 2005. PMID: 15959450 Review. French.
-
Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?Expert Rev Vaccines. 2022 Nov;21(11):1541-1553. doi: 10.1080/14760584.2022.2117693. Epub 2022 Sep 5. Expert Rev Vaccines. 2022. PMID: 36039786 Review.
Cited by
-
Evaluating the COVID-19 impact in Italian regions via multi criteria analysis.PLoS One. 2023 May 10;18(5):e0285452. doi: 10.1371/journal.pone.0285452. eCollection 2023. PLoS One. 2023. PMID: 37163510 Free PMC article.
References
-
- COVID-19 map—John Hopkins Univeristy;. https://coronavirus.jhu.edu/map.html.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical